Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study.

Publisher Correction: BMC Infectious Diseases (2022) 22:793 https://doi.org/10.1186/s12879-02... In the original publication of this article [[1]] the footnotes of Figure 1 were accidentally omitted during the publication process. 1Patients affected by haematological malignancies/autoimmune diseases...

Descripción completa

Detalles Bibliográficos
Publicado en:	BMC Infectious Diseases Vol. 22; no. 1; pp. 1 - 4
Autores principales:	Scaglione, Vincenzo, Rotundo, Salvatore, Marascio, Nadia, De Marco, Carmela, Lionello, Rosaria, Veneziano, Claudia, Berardelli, Lavinia, Quirino, Angela, Olivadese, Vincenzo, Serapide, Francesca, Tassone, Bruno, Morrone, Helen Linda, Davoli, Chiara, La Gamba, Valentina, Bruni, Andrea, Cesana, Bruno Mario, Matera, Giovanni, Russo, Alessandro, Costanzo, Francesco Saverio, Viglietto, Giuseppe
Formato:	Journal Article
Publicado:	BioMed Central 11/25/2022
Acceso en línea:	Ver este registro en EBSCOhost

Descripción
Sumario:	Publisher Correction: BMC Infectious Diseases (2022) 22:793 https://doi.org/10.1186/s12879-02... In the original publication of this article [[1]] the footnotes of Figure 1 were accidentally omitted during the publication process. 1Patients affected by haematological malignancies/autoimmune diseases or treated with immunosuppressive drugs or transplant receivers; 2First choice in patients with eGFR > 30 ml/min and no major drug interactions; 3Useful in patients with eGFR > 30 ml/min if major drug interactions contraindicate nirmatrelvir/ritonavir or in patients with dysphagia; 4For use in patients with severe renal insufficiency and/or partially immunised (i.e., previous SARS-CoV-2 infection, vaccination course incomplete or completed more than 6 months before); 5mAbs therapy was chosen considering local epidemiology of variants of concern Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.